Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cozzi Lepri

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Clinical and Experimental Immunology|December 22, 1999
Adrenaline-induced mobilization of T cells in HIV-infected patientsS R Søndergaard, A Cozzi Lepri, H Ullum, et al.
HIV Medicine|December 28, 2020
Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) studyJ D Baxter, D Dunn, A Tostevin, et al.
HIV Medicine|August 24, 2010
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008M C F Prosperi, A Cozzi-Lepri, A Antinori, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2017
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015B Rossetti, F Bai, A Tavelli, et al.
Infection|January 31, 2008
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilisP Cicconi, A Cozzi-lepri, G Orlando, et al.
HIV Medicine|June 30, 2010
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposureF Tordato, A Cozzi Lepri, P Cicconi, et al.
International Journal of Antimicrobial Agents|September 12, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?A Vergori, R Gagliardini, N Gianotti, et al.
HIV Medicine|May 31, 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparisonL Taramasso, A Di Biagio, F Maggiolo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2010
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort studyM C F Prosperi, A Cozzi-Lepri, A Castagna, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Clinical and Experimental Immunology|December 22, 1999
Adrenaline-induced mobilization of T cells in HIV-infected patientsS R Søndergaard, A Cozzi Lepri, H Ullum, et al.
HIV Medicine|December 28, 2020
Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) studyJ D Baxter, D Dunn, A Tostevin, et al.
HIV Medicine|August 24, 2010
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008M C F Prosperi, A Cozzi-Lepri, A Antinori, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2017
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015B Rossetti, F Bai, A Tavelli, et al.
Infection|January 31, 2008
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilisP Cicconi, A Cozzi-lepri, G Orlando, et al.
HIV Medicine|June 30, 2010
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposureF Tordato, A Cozzi Lepri, P Cicconi, et al.
International Journal of Antimicrobial Agents|September 12, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter?A Vergori, R Gagliardini, N Gianotti, et al.
HIV Medicine|May 31, 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparisonL Taramasso, A Di Biagio, F Maggiolo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2010
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort studyM C F Prosperi, A Cozzi-Lepri, A Castagna, et al.
Pageof 6